NovoCure Balance Sheet Health

Financial Health criteria checks 4/6

NovoCure has a total shareholder equity of $360.8M and total debt of $654.5M, which brings its debt-to-equity ratio to 181.4%. Its total assets and total liabilities are $1.2B and $861.2M respectively.

Key information

181.4%

Debt to equity ratio

US$654.48m

Debt

Interest coverage ration/a
CashUS$959.90m
EquityUS$360.78m
Total liabilitiesUS$861.21m
Total assetsUS$1.22b

Recent financial health updates

Recent updates

Analyst Estimates: Here's What Brokers Think Of NovoCure Limited (NASDAQ:NVCR) After Its Third-Quarter Report

Nov 01
Analyst Estimates: Here's What Brokers Think Of NovoCure Limited (NASDAQ:NVCR) After Its Third-Quarter Report

Is NovoCure (NASDAQ:NVCR) A Risky Investment?

Oct 17
Is NovoCure (NASDAQ:NVCR) A Risky Investment?

NovoCure: There Is Still More Upside

Oct 16

NovoCure's Stock Stagnates Amid Lack Of Progress Beyond GBM

Oct 09

Investors Appear Satisfied With NovoCure Limited's (NASDAQ:NVCR) Prospects

Sep 12
Investors Appear Satisfied With NovoCure Limited's (NASDAQ:NVCR) Prospects

NovoCure Limited: A Post Q2 Analysis

Jul 26

NovoCure Limited Q1 Earnings: Core Business Accelerating

May 03

NovoCure (NASDAQ:NVCR) Has Debt But No Earnings; Should You Worry?

Apr 08
NovoCure (NASDAQ:NVCR) Has Debt But No Earnings; Should You Worry?

NovoCure: Sell The METIS-Inspired Rally

Mar 28

Some Shareholders Feeling Restless Over NovoCure Limited's (NASDAQ:NVCR) P/S Ratio

Mar 03
Some Shareholders Feeling Restless Over NovoCure Limited's (NASDAQ:NVCR) P/S Ratio

NovoCure: Stay Cautious Amid Positive Signs

Jan 19

Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?

Nov 16
Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?

Is NovoCure (NASDAQ:NVCR) Weighed On By Its Debt Load?

Aug 13
Is NovoCure (NASDAQ:NVCR) Weighed On By Its Debt Load?

Is NovoCure (NASDAQ:NVCR) A Risky Investment?

May 15
Is NovoCure (NASDAQ:NVCR) A Risky Investment?

A Look At The Intrinsic Value Of NovoCure Limited (NASDAQ:NVCR)

Apr 24
A Look At The Intrinsic Value Of NovoCure Limited (NASDAQ:NVCR)

Why NovoCure Limited (NASDAQ:NVCR) Could Be Worth Watching

Feb 10
Why NovoCure Limited (NASDAQ:NVCR) Could Be Worth Watching

Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?

Jan 16
Does NovoCure (NASDAQ:NVCR) Have A Healthy Balance Sheet?

Financial Position Analysis

Short Term Liabilities: NVCR's short term assets ($1.1B) exceed its short term liabilities ($735.0M).

Long Term Liabilities: NVCR's short term assets ($1.1B) exceed its long term liabilities ($126.2M).


Debt to Equity History and Analysis

Debt Level: NVCR has more cash than its total debt.

Reducing Debt: NVCR's debt to equity ratio has increased from 78.5% to 181.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NVCR has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if NVCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies